Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals, including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical businesses working to address unmet medical needs in oncology and autoimmune diseases.As of 25 May 2026, Jubilant Pharmova share price is ₹1,007.25. The stock opened at ₹1,006.45, compared to its previous close of ₹1,006.35. During today's trading session, Jubilant Pharmova share price moved in the range of ₹955.25 to ₹1,014.90, with an average price of ₹985.08 for the day. Looking at its last 52-week, the stock has touched a low of ₹955.25 and a high of ₹1,014.90. On the performance front, Jubilant Pharmova share price has declined by 7.40% over the last six months and is down 6.22% on a year-on-year basis.
The market capitalization of Jubilant Pharmova is ₹16,022 Crs, with a P/E ratio of 40.3 and a dividend yield of 0.50%.